EN2: A candidate antigen for the development of targeted therapies in ovarian cancer.

e15528 Background: Ovarian cancer remains the most lethal gynaecologic tumour in the Western world. Stimulation of the immune system to consolidate response to chemotherapy can potentially be benef...